These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 36607480)
41. Neoisoliquiritin exerts tumor suppressive effects on prostate cancer by repressing androgen receptor activity. Chen C; Shao R; Li B; Zhai Y; Wang T; Li X; Miao L; Huang J; Liu R; Liu E; Zhu Y; Gao X; Zhang H; Wang Y Phytomedicine; 2021 May; 85():153514. PubMed ID: 33676083 [TBL] [Abstract][Full Text] [Related]
42. Novel anti-prostate cancer curcumin analogues that enhance androgen receptor degradation activity. Shi Q; Shih CC; Lee KH Anticancer Agents Med Chem; 2009 Oct; 9(8):904-12. PubMed ID: 19663790 [TBL] [Abstract][Full Text] [Related]
43. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells. Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834 [TBL] [Abstract][Full Text] [Related]
44. Effects of Curcumin Combined With the 5-alpha Reductase Inhibitor Dutasteride on LNCaP Prostate Cancer Cells. Nakayama A; Ide H; Lu Y; Takei A; Fukuda K; Osaka A; Arai G; Horie S; Okada H; Saito K In Vivo; 2021; 35(3):1443-1450. PubMed ID: 33910821 [TBL] [Abstract][Full Text] [Related]
45. Lipid nanoparticles to silence androgen receptor variants for prostate cancer therapy. Quick J; Santos ND; Cheng MHY; Chander N; Brimacombe CA; Kulkarni J; van der Meel R; Tam YYC; Witzigmann D; Cullis PR J Control Release; 2022 Sep; 349():174-183. PubMed ID: 35780952 [TBL] [Abstract][Full Text] [Related]
46. FCX, an arylidene derivative, induces apoptosis in androgen receptor-selective prostate cancer cells. Prasanna R; Elbessoumy AA; Chandramoorthy HC; Dera A; Al Fayi M J Cancer Res Ther; 2021; 17(2):401-407. PubMed ID: 34121684 [TBL] [Abstract][Full Text] [Related]
47. CDK inhibitors induce mitochondria-mediated apoptosis through the activation of polyamine catabolic pathway in LNCaP, DU145 and PC3 prostate cancer cells. Arisan ED; Obakan P; Coker-Gurkan A; Calcabrini A; Agostinelli E; Unsal NP Curr Pharm Des; 2014; 20(2):180-8. PubMed ID: 23701543 [TBL] [Abstract][Full Text] [Related]
48. Curcumin blocks the activation of androgen and interlukin-6 on prostate-specific antigen expression in human prostatic carcinoma cells. Tsui KH; Feng TH; Lin CM; Chang PL; Juang HH J Androl; 2008; 29(6):661-8. PubMed ID: 18676361 [TBL] [Abstract][Full Text] [Related]
49. Antitumor agents 290. Design, synthesis, and biological evaluation of new LNCaP and PC-3 cytotoxic curcumin analogs conjugated with anti-androgens. Shi Q; Wada K; Ohkoshi E; Lin L; Huang R; Morris-Natschke SL; Goto M; Lee KH Bioorg Med Chem; 2012 Jul; 20(13):4020-31. PubMed ID: 22672984 [TBL] [Abstract][Full Text] [Related]
51. Berberine, a natural product, induces G1-phase cell cycle arrest and caspase-3-dependent apoptosis in human prostate carcinoma cells. Mantena SK; Sharma SD; Katiyar SK Mol Cancer Ther; 2006 Feb; 5(2):296-308. PubMed ID: 16505103 [TBL] [Abstract][Full Text] [Related]
52. Inositol hexaphosphate inhibits growth and induces G1 arrest and apoptotic death of androgen-dependent human prostate carcinoma LNCaP cells. Agarwal C; Dhanalakshmi S; Singh RP; Agarwal R Neoplasia; 2004; 6(5):646-59. PubMed ID: 15548374 [TBL] [Abstract][Full Text] [Related]
53. The andean anticancer herbal product BIRM causes destabilization of androgen receptor and induces caspase-8 mediated-apoptosis in prostate cancer. Shamaladevi N; Araki S; Lyn DA; Ayyathurai R; Gao J; Lokeshwar VB; Navarrete H; Lokeshwar BL Oncotarget; 2016 Dec; 7(51):84201-84213. PubMed ID: 27705939 [TBL] [Abstract][Full Text] [Related]
54. Evaluation of the effects of androgenic Chinese herbal medicines on androgen receptors and tumor growth in experimental prostate cancer models. Zhang ZB; Ip SP; Cho WC; Hu Z; Huang YF; Luo DD; Xian YF; Lin ZX J Ethnopharmacol; 2020 Oct; 260():113058. PubMed ID: 32525068 [TBL] [Abstract][Full Text] [Related]
55. Establishment and characterization of androgen-independent human prostate cancer cell lines, LN-REC4 and LNCaP-SF, from LNCaP. Iwasa Y; Mizokami A; Miwa S; Koshida K; Namiki M Int J Urol; 2007 Mar; 14(3):233-9. PubMed ID: 17430262 [TBL] [Abstract][Full Text] [Related]
56. [Up-regulates the expression of maspin gene in prostate cancer cell line LNCaP]. Shi P; Chen WW; Hu XY; Yu CX; Zhang PJ; Jiang AL; Zhang JY Yao Xue Xue Bao; 2006 Dec; 41(12):1152-6. PubMed ID: 17290611 [TBL] [Abstract][Full Text] [Related]
57. Progression of LNCaP prostate tumor cells during androgen deprivation: hormone-independent growth, repression of proliferation by androgen, and role for p27Kip1 in androgen-induced cell cycle arrest. Kokontis JM; Hay N; Liao S Mol Endocrinol; 1998 Jul; 12(7):941-53. PubMed ID: 9658399 [TBL] [Abstract][Full Text] [Related]
58. Curcumin sensitizes prostate cancer cells to tumor necrosis factor-related apoptosis-inducing ligand/Apo2L by inhibiting nuclear factor-kappaB through suppression of IkappaBalpha phosphorylation. Deeb D; Jiang H; Gao X; Hafner MS; Wong H; Divine G; Chapman RA; Dulchavsky SA; Gautam SC Mol Cancer Ther; 2004 Jul; 3(7):803-12. PubMed ID: 15252141 [TBL] [Abstract][Full Text] [Related]
59. Androgen receptor-dependent regulation of Bcl-xL expression: Implication in prostate cancer progression. Sun A; Tang J; Hong Y; Song J; Terranova PF; Thrasher JB; Svojanovsky S; Wang HG; Li B Prostate; 2008 Mar; 68(4):453-61. PubMed ID: 18196538 [TBL] [Abstract][Full Text] [Related]
60. Piperine, a Bioactive Component of Pepper Spice Exerts Therapeutic Effects on Androgen Dependent and Androgen Independent Prostate Cancer Cells. Samykutty A; Shetty AV; Dakshinamoorthy G; Bartik MM; Johnson GL; Webb B; Zheng G; Chen A; Kalyanasundaram R; Munirathinam G PLoS One; 2013; 8(6):e65889. PubMed ID: 23824300 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]